CENCORA INC (COR)
US03073E1055 - Common Stock
Overall COR gets a fundamental rating of 5 out of 10. We evaluated COR against 113 industry peers in the Health Care Providers & Services industry. COR scores excellent on profitability, but there are some minor concerns on its financial health. COR is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
COR had positive earnings in the past year.
In the past year COR had a positive cash flow from operations.
Of the past 5 years COR 4 years were profitable.
COR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of COR (2.25%) is better than 67.26% of its industry peers.
With an excellent Return On Equity value of 191.82%, COR belongs to the best of the industry, outperforming 99.11% of the companies in the same industry.
COR has a better Return On Invested Capital (18.81%) than 94.69% of its industry peers.
COR had an Average Return On Invested Capital over the past 3 years of 16.75%. This is significantly above the industry average of 8.10%.
The last Return On Invested Capital (18.81%) for COR is above the 3 year average (16.75%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.25% | ||
| ROE | 191.82% | ||
| ROIC | 18.81% |
ROA(3y)2.68%
ROA(5y)0.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.75%
ROIC(5y)15.69%
1.3 Margins
The Profit Margin of COR (0.51%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of COR has grown nicely.
COR's Operating Margin of 1.05% is in line compared to the rest of the industry. COR outperforms 45.13% of its industry peers.
COR's Operating Margin has been stable in the last couple of years.
COR's Gross Margin of 3.35% is on the low side compared to the rest of the industry. COR is outperformed by 83.19% of its industry peers.
In the last couple of years the Gross Margin of COR has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.05% | ||
| PM (TTM) | 0.51% | ||
| GM | 3.35% |
OM growth 3Y-4.94%
OM growth 5Y0.65%
PM growth 3Y-10.65%
PM growth 5Y1.52%
GM growth 3Y2.12%
GM growth 5Y3.93%
2. Health
2.1 Basic Checks
COR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for COR has been reduced compared to 1 year ago.
COR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, COR has an improved debt to assets ratio.
2.2 Solvency
COR has a debt to FCF ratio of 1.46. This is a very positive value and a sign of high solvency as it would only need 1.46 years to pay back of all of its debts.
COR has a better Debt to FCF ratio (1.46) than 89.38% of its industry peers.
COR has a Debt/Equity ratio of 4.84. This is a high value indicating a heavy dependency on external financing.
COR has a worse Debt to Equity ratio (4.84) than 80.53% of its industry peers.
Although COR does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.84 | ||
| Debt/FCF | 1.46 | ||
| Altman-Z | N/A |
ROIC/WACC2.18
WACC8.62%
2.3 Liquidity
COR has a Current Ratio of 0.88. This is a bad value and indicates that COR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.88, COR is doing worse than 79.65% of the companies in the same industry.
A Quick Ratio of 0.53 indicates that COR may have some problems paying its short term obligations.
With a Quick ratio value of 0.53, COR is not doing good in the industry: 85.84% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
COR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.76%, which is quite good.
COR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.21% yearly.
Looking at the last year, COR shows a quite strong growth in Revenue. The Revenue has grown by 12.12% in the last year.
The Revenue has been growing by 10.36% on average over the past years. This is quite good.
EPS 1Y (TTM)14.76%
EPS 3Y14.11%
EPS 5Y14.21%
EPS Q2Q%16.78%
Revenue 1Y (TTM)12.12%
Revenue growth 3Y11.16%
Revenue growth 5Y10.36%
Sales Q2Q%14.69%
3.2 Future
The Earnings Per Share is expected to grow by 10.11% on average over the next years. This is quite good.
Based on estimates for the next years, COR will show a small growth in Revenue. The Revenue will grow by 6.28% on average per year.
EPS Next Y9.45%
EPS Next 2Y9.24%
EPS Next 3Y9.01%
EPS Next 5Y10.11%
Revenue Next Year8.1%
Revenue Next 2Y7.14%
Revenue Next 3Y6.59%
Revenue Next 5Y6.28%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 17.81, COR is valued on the expensive side.
Based on the Price/Earnings ratio, COR is valued a bit cheaper than the industry average as 76.99% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 29.20. COR is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 16.27, which indicates a correct valuation of COR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COR indicates a somewhat cheap valuation: COR is cheaper than 77.88% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.00, COR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.81 | ||
| Fwd PE | 16.27 |
4.2 Price Multiples
83.19% of the companies in the same industry are more expensive than COR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.11 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
COR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.89
PEG (5Y)1.25
EPS Next 2Y9.24%
EPS Next 3Y9.01%
5. Dividend
5.1 Amount
With a yearly dividend of 0.90%, COR is not a good candidate for dividend investing.
COR's Dividend Yield is rather good when compared to the industry average which is at 3.16. COR pays more dividend than 80.53% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.23, COR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
5.2 History
The dividend of COR has a limited annual growth rate of 5.31%.
COR has been paying a dividend for at least 10 years, so it has a reliable track record.
COR has decreased its dividend recently.
Dividend Growth(5Y)5.31%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
COR pays out 27.58% of its income as dividend. This is a sustainable payout ratio.
COR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP27.58%
EPS Next 2Y9.24%
EPS Next 3Y9.01%
CENCORA INC
NYSE:COR (11/22/2024, 8:04:00 PM)
After market: 246.71 +1.69 (+0.69%)245.02
-0.67 (-0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap48.28B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.81 | ||
| Fwd PE | 16.27 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.89
PEG (5Y)1.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.25% | ||
| ROE | 191.82% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 1.05% | ||
| PM (TTM) | 0.51% | ||
| GM | 3.35% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover4.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.84 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)14.76%
EPS 3Y14.11%
EPS 5Y
EPS Q2Q%
EPS Next Y9.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.12%
Revenue growth 3Y11.16%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y